Drug recall · October 1, 2014
Buprenorphine Hydrochloride Injection recall
Why: Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Buprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL ,1 mL, 10 Carpuject Sterile Cartridge Units with Luer Lock, Slim-Paks, F Intramuscular or Intravenous Use, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2012-32
- Lots / codes
Lot Number: 35-730-LL, 35-745-LL, Exp: 1 FEB 2015
- Quantity
- 373,180 Carpuject units
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- September 9, 2014 · Voluntary: Firm initiated
- Classified
- September 19, 2014
- Reported
- October 1, 2014
- Ended
- March 17, 2017
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Buprenorphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.